Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE)

Acta Neuropathologica · Published 2026-05-15 · DOI 10.1007/s00401-026-03027-0

Free full text

Authors (5)

Ling Wu, Tobilola Akingbade, Peter T. Nelson, Shih-Hsiu J. Wang, Bin Xu

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Wu, L., Akingbade, T., Nelson, P., et al. (2026). Molecular signatures and biomarker development for limbic-predominant age-related TDP-43 encephalopathy (LATE). Acta Neuropathologica. https://doi.org/10.1007/s00401-026-03027-0

Related articles

• A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer’s disease · Acta Neuropathologica · 2026 · Same journal
• Retinal proteome changes mirror brain pathology and reveal synaptic and cytoskeletal dysfunction in Alzheimer’s disease · Acta Neuropathologica · 2026 · Same journal
• APOE ε4 influences the widespread TDP-43 pathological subtype in sporadic amyotrophic lateral sclerosis · Acta Neuropathologica · 2026 · Same journal
• Neocortical tau burden determines the degree of cognitive impairment in individuals with Braak stage V neurofibrillary degeneration · Acta Neuropathologica · 2026 · Same journal
• Consensus statement on microglial and macrophage functions in gliomas · Acta Neuropathologica · 2026 · Same journal
• Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model · Acta Neuropathologica · 2026 · Same journal
• Altered astrocyte–neuron crosstalk in progressive supranuclear palsy: integrated evidence from proteomics and magnetic resonance spectroscopy · Acta Neuropathologica · 2026 · Same journal
• CTE-type tau filaments in Alzheimer’s disease with co-morbid LATE-NC · Acta Neuropathologica · 2026 · Same journal
• A severe neurodevelopmental syndrome linked to a South Asian founder variant in the UFMylation adaptor CDK5RAP3 · Acta Neuropathologica · 2026 · Same journal
• A novel BEND2 monoclonal antibody enables highly specific immunohistochemical diagnosis of BEND2-fusion astroblastomas · Acta Neuropathologica · 2026 · Same journal